Bloomage Biotechnology Corp Ltd (688363) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥93.75 Million ≈ $13.72 Million USD) by net assets (CN¥7.09 Billion ≈ $1.04 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bloomage Biotechnology Corp Ltd balance sheet independence to measure how much of total assets are equity-financed.

Bloomage Biotechnology Corp Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Bloomage Biotechnology Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bloomage Biotechnology Corp Ltd (688363) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Bloomage Biotechnology Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bloomage Biotechnology Corp Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Cargotec Oyj
HE:CGCBV
0.087x
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
0.049x
Air China Limited
F:AD2
0.337x
Fibra Danhos
MX:DANHOS13
0.022x
West African Resources Ltd
AU:WAF
0.055x
Multiplan Empreendimentos Imobiliários S.A
SA:MULT3
0.056x
Hangzhou Cable
SHG:603618
-0.069x
Huaming Power Equipment Co Ltd
SHE:002270
0.013x

Annual Cash Flow Conversion Efficiency for Bloomage Biotechnology Corp Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Bloomage Biotechnology Corp Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Bloomage Biotechnology Corp Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥7.12 Billion
≈ $1.04 Billion
CN¥627.45 Million
≈ $91.82 Million
0.088x +6.85%
2024-12-31 CN¥6.84 Billion
≈ $1.00 Billion
CN¥564.51 Million
≈ $82.60 Million
0.083x -17.62%
2023-12-31 CN¥6.98 Billion
≈ $1.02 Billion
CN¥699.65 Million
≈ $102.38 Million
0.100x +5.41%
2022-12-31 CN¥6.68 Billion
≈ $977.93 Million
CN¥635.19 Million
≈ $92.95 Million
0.095x -57.53%
2021-12-31 CN¥5.70 Billion
≈ $834.45 Million
CN¥1.28 Billion
≈ $186.73 Million
0.224x +61.67%
2020-12-31 CN¥5.09 Billion
≈ $745.44 Million
CN¥705.12 Million
≈ $103.18 Million
0.138x +72.58%
2019-12-31 CN¥4.55 Billion
≈ $665.74 Million
CN¥364.89 Million
≈ $53.40 Million
0.080x -68.86%
2018-12-31 CN¥1.72 Billion
≈ $251.32 Million
CN¥442.30 Million
≈ $64.72 Million
0.258x +22.81%
2017-12-31 CN¥1.64 Billion
≈ $239.65 Million
CN¥343.42 Million
≈ $50.25 Million
0.210x +9.39%
2016-12-31 CN¥1.26 Billion
≈ $184.47 Million
CN¥241.68 Million
≈ $35.36 Million
0.192x +56.87%
2015-12-31 CN¥1.19 Billion
≈ $174.42 Million
CN¥145.67 Million
≈ $21.32 Million
0.122x -33.10%
2014-12-31 CN¥752.51 Million
≈ $110.12 Million
CN¥137.47 Million
≈ $20.12 Million
0.183x -33.62%
2013-12-31 CN¥564.35 Million
≈ $82.58 Million
CN¥155.33 Million
≈ $22.73 Million
0.275x +24.08%
2012-12-31 CN¥376.97 Million
≈ $55.16 Million
CN¥83.62 Million
≈ $12.24 Million
0.222x --

About Bloomage Biotechnology Corp Ltd

SHG:688363 China Specialty Chemicals
Market Cap
$2.68 Billion
CN¥18.34 Billion CNY
Market Cap Rank
#5245 Global
#924 in China
Share Price
CN¥38.08
Change (1 day)
-2.56%
52-Week Range
CN¥33.47 - CN¥60.00
All Time High
CN¥303.37
About

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature nam… Read more